The global market for pediatric medicines reached $80.7 billion in 2013 and should reach $83.6 billion in 2014. This market is expected to reach about $100.7 billion by 2019, registering a compound annual growth rate (CAGR) of 3.8% from 2014 to 2019.
This report provides:
An overview of the global market for pediatric medicines.
Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
Discussion on market drivers and inhibitors, and the area of unmet clinical need.
Information on the regulatory environment and impacts of government.
Details pertaining to the barriers to entry for pediatric medicines.
Market analysis for therapeutic fields including childhood cancers, CNS disorders, inflammatory diseases, metabolic diseases, respiratory conditions, vaccinations, and viral infections.
SCOPE OF REPORT
This new report on pediatric medicine will provide a brief overview on the current status of the industry and recent developments. It presents the changing environment in terms of new legislation and implementation of global pediatric plans. The report analyzes market trends and identifies key therapeutic and geographical challenges and rising opportunities in the developed and developing world. Finally, the report provides insights on how all stakeholders have an essential interest in prioritizing pediatric drug development targets and improving access to safe and effective medicines to children across the globe.